A study to evaluate the rate of muscle weakness remaining after cancer surgeries.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2024/03/063717
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA 1-3 adult patients undergoing elective onco-surgery under general anesthesia receiving non depolarizing muscle relaxants in the main OT (operation theatre) complex
Exclusion Criteria
1.Patient refusal
2.Age less than 18 years
3.Pregnant patients
4.Pre existing neuromuscular disease
5.Patients undergoing Neurosurgeries
6.Patients shifted to PACU on mechanical ventilation
7.Patients getting shifted to any other area than the recovery unit situated in the main OT complex.
8.Emergency surgeries and surgeries done on weekends
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To find the incidence of residual neuromuscular blockade (defined as TOF ratio less than 0.9) in the post anaesthesia care unit.Timepoint: Within 15 minutes
- Secondary Outcome Measures
Name Time Method 1.To determine the risk factors of residual neuromuscular blockade. <br/ ><br>2.To determine the incidence of adverse respiratory events occurring in the first 60 mins after arrival to post anaesthesia care unit (PACU) defined as, <br/ ><br>a.Oxygen saturation less than 93 percent <br/ ><br>b.Need for use of airway intervention during transport of patient or in PACU (jaw thrust, use of oral or nasal airway, mask ventilation) <br/ ><br>c.Need for reintubation <br/ ><br>Timepoint: within 60 minutes